Journals / Turkish Journal of Hematology / 2014 / Cilt: 31 - Sayı: 4

The Relationship of T Helper-2 Pathway Components Interleukin-4, Interleukin-10, Immunoglobulin E, and Eosinophils with Prognostic Markers in Non-Hodgkin Lymphoma: A Case-Control Study

Yardımcı T Lenfosit-2 Yolağı Bileşenlerinden İnterlökin-4, İnterlökin-10, İmmünglobülin E ve Eozinofiller'in Hodgkin-Dışı Lenfoma'nın Prognostik Belirteçleri ile Olan İlişkisi-Kontrollü Klinik Çalışma

Pages
381–387
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: There is a need for differently designed studies to detect the place of the Th2 pathway in NHL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Increased risk for non-Hodgkin lymphoma (NHL) is associated with infections and environmental agents.
📊
Key Findings & Data:We hypothesized that these factors chronically trigger the T helper-2 (Th2) pathway and result in lymphoma.
💡
Conclusion & Impact:Conclusion: There is a need for differently designed studies to detect the place of the Th2 pathway in NHL.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Increased risk for non-Hodgkin lymphoma (NHL) is associated with infections and environmental agents. We hypothesized that these factors chronically trigger the T helper-2 (Th2) pathway and result in lymphoma. We investigated the role of the Th2 pathway by exploring the relationships between components of the Th2 pathway, interleukin (IL)-10, IL-4, immunoglobulin E (IgE), and eosinophils, and prognostic markers of NHL.Materials and Methods:Thirty-one NHL patients and 27 healthy controls were enrolled. IL-10, IL-4, IgE, and eosinophils were measured. IL-4 and IL-10 were analyzed with the enzyme amplified sensitivity immunoassay method. Results:High IL-10 levels were correlated with several poor prognostic features, short early survival, and lymphopenia. There was a positive correlation between albumin and IL-4 levels and a negative correlation between IL-10 and albumin. There was no relationship related with eosinophils and IgE. We found remnant increased IL-4, which could be a clue for the triggering of the Th2 pathway in the background. Conclusion: There is a need for differently designed studies to detect the place of the Th2 pathway in NHL.

Özet

Amaç:Non-Hodgkin lenfoma (NHL) riski enfeksiyonlar ve çevresel ajanlarla artmış olarak ilişkilendirilmiştir. Hipotezimize göre bu faktörlere kronik olarak maruz kalmak T helper-2 (Th2) yolağını aktifler ve lenfomaya sebep olur. Bu amaçla Th2 yolağı komponentleri olan IL-10, IL-4, IgE, ve eozinofille, NHL'nin prognostik belirteçleri arasındaki ilişkiye baktık. Gereç ve Yöntemler:Otuz bir NHL hastası ve 27 sağlıklı kontrolde IL-10, IL-4, IgE ve eozinofil değerlerine bakıldı. IL-4 ve IL-10 EASIA metodu ile ölçüldü.Bulgular: Yüksek IL-10 düzeyleri pek çok kötü prognostik özellikle, çok kısa yaşam süresi ve lenfopeni ile ilişkiliydi. Albümin açısından IL-10 ile negatif ilişki, IL-4 ile pozitif ilişki bulundu. Eozinofil ve IgE ile ilgili herhangi bir ilişki kurulamadı. Bazı hastalarda gözlenen artmış IL-4 geri planda kalmış Th2 yolağı aktivasyonunun bir ip ucu olabilir.Sonuç: Th2 yolağının NHL patogenezindeki yerini tespit etmek için farklı dizaynlarda çalışmalara ihtiyaç vardır.

🔖

Cite This Article

GÜLER, N., KELKİTLİ, E., ATAY, M. H., ERDEM, D., ALAÇAM, H., BEK, Y., ÖZATLI, D., TURGUT, M., YILDIZ, L., YÜCEL, İ. (2014). The Relationship of T Helper-2 Pathway Components Interleukin-4, Interleukin-10, Immunoglobulin E, and Eosinophils with Prognostic Markers in Non-Hodgkin Lymphoma: A Case-Control Study. Turkish Journal of Hematology, Cilt: 31 - Sayı: 4, 381–387. https://ajindex.com/articles/413124

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Oliphant CJ, Barlow JL, McKenzie AN. Insights into the initiation of type 2 immune responses. Immunology 2011;134:378-385
  2. Chapoval S, Dasgupta P, Dorsey NJ, Keegan AD. Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J Leukoc Biol 2010;87:1011- 1018
  3. Roncarolo MG, Battaglia M, Gregori S. The role of interleukin 10 in the control of autoimmunity. J Autoimmun 2003;20:269-272
  4. Commins S, Steinke JW, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 2008;121:1108-1111
  5. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150:353-360
  6. Askenasy N, Kaminitz A, Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun Rev 2008;7:370-375
  7. Chang TL, Peng X, Fu XY. Interleukin-4 mediates cell growth inhibition through activation of Stat-1. J Biol Chem 2000;275:10212-10217
  8. Defrance T, Fluckiger AC, Rossi JF, Magaud JP, Sotto JJ, Banchereau J. Antiproliferative effects of interleukin-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells. Blood 1992;79:990-996 9. Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot MC. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 1993;82:2169-2174. 10.Cortes JE, Talpaz M, Cabanillas F, Seymour JF, Kurzrock R. Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis. Blood 1995;85:2516-2520
  9. Lech-Maranda E, Bienvenu J, Michallet AS, Houot R, Robak T, Coiffier B, Salles G. Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma. Eur Cytokine Netw 2006;17:60-66
  10. Nacinovic-Duletic A, Stifter S, Dvornik S, Skunca Z, Jonjic N. Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma. Int J Lab Hematol 2008;30:230-239. 13.Guney N, Soydinc HO, Basaran M, Bavbek S, Derin D, Camlica H, Yasasever V, Topuz E. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma. Asian Pac J Cancer Prev 2009;10:669-674
  11. Fabre-Guillevin E, Tabrizi R, Coulon V, Monnereau A, Eghbali H, Soubeyran I, Soubeyran P. Ag